A Novel Strategy To Screen Bacillus Calmette-Guerin Protein Antigen Recognized By Gamma Delta Tcr

XueYan Xi,XiaoYan Zhang,Bei Wang,Ji Wang,He Huang,LianXian Cui,XiQin Han,Liang Li,Wei He,ZhenDong Zhao

DOI: https://doi.org/10.1371/journal.pone.0018809

IF: 3.7

2011-01-01

PLoS ONE

Abstract:BACKGROUND: Phosphoantigen was originally identified as the main gamma delta TCR-recognized antigen that could activate gamma delta T cells to promote immune protection against mycobacterial infection. However, new evidence shows that the gamma delta T cells activated by phosphoantigen can only provide partial immune protection against mycobacterial infection. In contrast, whole lysates of Mycobacterium could activate immune protection more potently, implying that other gamma delta TCR-recognized antigens that elicit protective immune responses. To date, only a few distinct mycobacterial antigens recognized by the gamma delta TCR have been characterized.METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we established a new approach to screen epitopes or protein antigens recognized by the gamma delta TCR using Bacillus Calmette-Guerin- (BCG-) specific gamma delta TCR transfected cells as probes to pan a 12-mer random-peptide phage-displayed library. Through binding assays and functional analysis, we identified a peptide (BP3) that not only binds to the BCG-specific gamma delta TCR but also effectively activates gamma delta T cells isolated from human subjects inoculated with BCG. Importantly, the gamma delta T cells activated by peptide BP3 had a cytotoxic effect on THP-1 cells infected with BCG. Moreover, the oxidative stress response regulatory protein (OXYS), a BCG protein that matches perfectly with peptide BP3 according to bioinformatics analysis, was confirmed as a ligand for the gamma delta TCR and was found to activate gamma delta T cells from human subjects inoculated with BCG.CONCLUSIONS/SIGNIFICANCE: In conclusion, our study provides a novel strategy to identify epitopes or protein antigens for the gamma delta TCR, and provides a potential means to screen mycobacterial vaccines or candidates for adjuvant.